Literature DB >> 26263412

Raman spectroscopy for label-free identification of calciphylaxis.

William R Lloyd1, Shailesh Agarwal2, Sagar U Nigwekar3, Karen Esmonde-White4, Shawn Loder2, Shawn Fagan5, Jeremy Goverman5, Bjorn R Olsen6, Dolrudee Jumlongras6, Michael D Morris1, Benjamin Levi2.   

Abstract

Calciphylaxis is a painful, debilitating, and premorbid condition, which presents as calcified vasculature and soft tissues. Traditional diagnosis of calciphylaxis lesions requires an invasive biopsy, which is destructive, time consuming, and often leads to exacerbation of the condition and infection. Furthermore, it is difficult to find small calcifications within a large wound bed. To address this need, a noninvasive diagnostic tool may help clinicians identify ectopic calcified mineral and determine the disease margin. We propose Raman spectroscopy as a rapid, point-of-care, noninvasive, and label-free technology to detect calciphylaxis mineral. Debrided calciphylactic tissue was collected from six patients and assessed by microcomputed tomography (micro-CT). Micro-CT confirmed extensive deposits in three specimens, which were subsequently examined with Raman spectroscopy. Raman spectra confirmed that deposits were consistent with carbonated apatite, consistent with the literature. Raman spectroscopy shows potential as a noninvasive technique to detect calciphylaxis in a clinical environment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26263412      PMCID: PMC4689104          DOI: 10.1117/1.JBO.20.8.080501

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  23 in total

Review 1.  Evolution of treatment strategies for calciphylaxis.

Authors:  Edward A Ross
Journal:  Am J Nephrol       Date:  2011-10-06       Impact factor: 3.754

2.  Calciphylaxis: natural history, risk factor analysis, and outcome.

Authors:  Roger H Weenig; Lindsay D Sewell; Mark D P Davis; James T McCarthy; Mark R Pittelkow
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

Review 3.  Calciphylaxis: a systematic review of existing and emerging therapies.

Authors:  Chetan Vedvyas; Laura S Winterfield; Ruth Ann Vleugels
Journal:  J Am Acad Dermatol       Date:  2011-08-06       Impact factor: 11.527

Review 4.  Biochemical and molecular aspects of spectral diagnosis in calcinosis cutis.

Authors:  Shan-Yang Lin
Journal:  Expert Rev Mol Med       Date:  2014-03-11       Impact factor: 5.600

5.  Cutaneous calciphylaxis. An underrecognized clinicopathologic entity.

Authors:  L R Essary; M R Wick
Journal:  Am J Clin Pathol       Date:  2000-02       Impact factor: 2.493

Review 6.  Calciphylaxis: a still unmet challenge.

Authors:  Vincent M Brandenburg; Mario Cozzolino; Markus Ketteler
Journal:  J Nephrol       Date:  2011 Mar-Apr       Impact factor: 3.902

7.  Sodium thiosulfate therapy for calcific uremic arteriolopathy.

Authors:  Sagar U Nigwekar; Steven M Brunelli; Debra Meade; Weiling Wang; Jeffrey Hymes; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 8.237

Review 8.  Calciphylaxis cutis: a case report and review of literature.

Authors:  Mahmoud-Rezk A Hussein; Hayder O Ali; Saad R Abdulwahed; Yahia Argoby; Faisal H Tobeigei
Journal:  Exp Mol Pathol       Date:  2009-04       Impact factor: 3.362

Review 9.  Cutaneous necrosis from calcific uremic arteriolopathy.

Authors:  T Coates; G S Kirkland; R B Dymock; B F Murphy; J K Brealey; T H Mathew; A P Disney
Journal:  Am J Kidney Dis       Date:  1998-09       Impact factor: 8.860

10.  Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data.

Authors:  Hermann Salmhofer; Michael Franzen; Wolfgang Hitzl; Josef Koller; Bernhard Kreymann; Falko Fend; Cornelia Hauser-Kronberger; Uwe Heemann; Frieder Berr; Christoph Schmaderer
Journal:  Kidney Blood Press Res       Date:  2013-09-22       Impact factor: 2.687

View more
  5 in total

1.  Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.

Authors:  Hester Colboc; Philippe Moguelet; Dominique Bazin; Priscille Carvalho; Anne-Sophie Dillies; Guillaume Chaby; Hervé Maillard; Diane Kottler; Elisa Goujon; Christine Jurus; Marine Panaye; Vincent Frochot; Emmanuel Letavernier; Michel Daudon; Ivan Lucas; Raphaël Weil; Philippe Courville; Jean-Benoit Monfort; François Chasset; Patricia Senet
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

Review 2.  Calciphylaxis.

Authors:  Sagar U Nigwekar
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-07       Impact factor: 2.894

3.  Combined reflectance and Raman spectroscopy to assess degree of in vivo angiogenesis after tissue injury.

Authors:  Shailesh Agarwal; William R Lloyd; Shawn J Loder; Michael T Chung; Charles Hwang; Michael D Morris; Benjamin Levi
Journal:  J Surg Res       Date:  2016-09-19       Impact factor: 2.192

4.  Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.

Authors:  Hansjörg Rothe; Vincent Brandenburg; Margot Haun; Barbara Kollerits; Florian Kronenberg; Markus Ketteler; Christoph Wanner
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

Review 5.  Calciphylaxis and its diagnosis: A review.

Authors:  Deepak Baby; Meenakshi Upadhyay; M Derick Joseph; Swati Joshi Asopa; Basanta Kumar Choudhury; Jagadish Prasad Rajguru; Shivangi Gupta
Journal:  J Family Med Prim Care       Date:  2019-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.